Fresenius Kabi USA, LLC Recalls

Fresenius Kabi USA Recalls Famotidine Injection Over Contamination Risk

Fresenius Kabi USA, LLC recalled 2,199,850 vials of Famotidine Injection on November 6, 2025. The recall follows reports of microbial contamination and endotoxin testing failures. Healthcare providers and consumers should stop using this product immediately.